Myriad Genetics Inc (MYGN)

Debt-to-equity ratio

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Long-term debt	US$ in thousands	—	—	—	—	—
Total stockholders’ equity	US$ in thousands	701,100	783,200	885,800	967,800	881,000
Debt-to-equity ratio		0.00	0.00	0.00	0.00	0.00

December 31, 2024 calculation

Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $701,100K
= 0.00

Based on the data provided, Myriad Genetics Inc has consistently maintained a debt-to-equity ratio of 0.00 from December 31, 2020, to December 31, 2024. This indicates that the company has not utilized any debt in its capital structure relative to its equity during this time period. A debt-to-equity ratio of 0.00 signifies that the company's financing is primarily equity-based, which could suggest a conservative financial strategy or a strong balance sheet position. It is important to note that a low or zero debt-to-equity ratio does not necessarily imply a disadvantage, as it depends on the industry and business model of the company. Overall, Myriad Genetics Inc's consistent 0.00 debt-to-equity ratio may indicate financial stability and a lower risk of financial distress related to debt obligations.